Response by Parkash et al to letters regarding article, "effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])"

Ratika Parkash; John L. Sapp; Jeff S. Healey; Anthony S.L. Tang

doi:10.1161/CIRCULATIONAHA.117.030177

Response by Parkash et al to letters regarding article, "effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])"

Ratika Parkash, John L. Sapp, Jeff S. Healey, Anthony S.L. Tang

Producción científica: Contribución a una revista › Carta › revisión exhaustiva

Idioma original	English
Páginas (desde-hasta)	1271-1272
Número de páginas	2
Publicación	Circulation
Volumen	136
N.º	13
DOI	https://doi.org/10.1161/CIRCULATIONAHA.117.030177
Estado	Published - sep. 1 2017
Publicado de forma externa	Sí

Nota bibliográfica

Funding Information:
Dr Parkash has received research grants from Bayer, Pfizer, Medtronic, and Abbott. Dr Sapp has received research grants from Abbott and Biosense Webster. Dr Healey has received research grants from Pfizer.

ASJC Scopus Subject Areas

Cardiology and Cardiovascular Medicine
Physiology (medical)

Acceder al documento

10.1161/CIRCULATIONAHA.117.030177

Otros archivos y enlaces

Citar esto

Parkash, R., Sapp, J. L., Healey, J. S., & Tang, A. S. L. (2017). Response by Parkash et al to letters regarding article, "effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])". Circulation, 136(13), 1271-1272. https://doi.org/10.1161/CIRCULATIONAHA.117.030177

Response by Parkash et al to letters regarding article, "effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])". / Parkash, Ratika; Sapp, John L.; Healey, Jeff S. et al.
En: Circulation, Vol. 136, N.º 13, 01.09.2017, p. 1271-1272.

Producción científica: Contribución a una revista › Carta › revisión exhaustiva

Parkash, R, Sapp, JL, Healey, JS & Tang, ASL 2017, 'Response by Parkash et al to letters regarding article, "effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])"', Circulation, vol. 136, n.º 13, pp. 1271-1272. https://doi.org/10.1161/CIRCULATIONAHA.117.030177

Parkash R, Sapp JL, Healey JS, Tang ASL. Response by Parkash et al to letters regarding article, "effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])". Circulation. 2017 sept. 1;136(13):1271-1272. doi: 10.1161/CIRCULATIONAHA.117.030177

Parkash, Ratika ; Sapp, John L. ; Healey, Jeff S. et al. / Response by Parkash et al to letters regarding article, "effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation : A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])". En: Circulation. 2017 ; Vol. 136, N.º 13. pp. 1271-1272.

@article{6e9fa6963aaf460eb2eb4636291b4a87,

title = "Response by Parkash et al to letters regarding article, {"}effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation: A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control]){"}",

author = "Ratika Parkash and Sapp, {John L.} and Healey, {Jeff S.} and Tang, {Anthony S.L.}",

note = "Funding Information: Dr Parkash has received research grants from Bayer, Pfizer, Medtronic, and Abbott. Dr Sapp has received research grants from Abbott and Biosense Webster. Dr Healey has received research grants from Pfizer.",

year = "2017",

month = sep,

day = "1",

doi = "10.1161/CIRCULATIONAHA.117.030177",

language = "English",

volume = "136",

pages = "1271--1272",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "13",

}

TY - JOUR

T1 - Response by Parkash et al to letters regarding article, "effect of aggressive blood pressure control on the recurrence of atrial fibrillation after catheter ablation

T2 - A randomized, open-label clinical trial (SMAC-AF [substrate modification with aggressive blood pressure control])"

AU - Parkash, Ratika

AU - Sapp, John L.

AU - Healey, Jeff S.

AU - Tang, Anthony S.L.

N1 - Funding Information: Dr Parkash has received research grants from Bayer, Pfizer, Medtronic, and Abbott. Dr Sapp has received research grants from Abbott and Biosense Webster. Dr Healey has received research grants from Pfizer.

PY - 2017/9/1

Y1 - 2017/9/1

UR - http://www.scopus.com/inward/record.url?scp=85030979776&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030979776&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.117.030177

DO - 10.1161/CIRCULATIONAHA.117.030177

M3 - Letter

C2 - 28947486

AN - SCOPUS:85030979776

SN - 0009-7322

VL - 136

SP - 1271

EP - 1272

JO - Circulation

JF - Circulation

IS - 13

ER -